Log in / Register
Home arrow Health arrow High Density Lipoproteins

A short course of lectures
«High Density Lipoproteins»

Effects of HDL on ObesityNiacinHigh-Density Lipoproteins, Environmental Pathogens and ToxinsMaking Sense of AntisenseHDL ProteomicsEpidemiology: Disease AssociationsNiacinHDL Potential Effects on the Blood–Brain BarrierTherapeutic Antisense Oligonucleotides for the Increase of HDL-Cholesterol Levels and Improvement of HDL FunctionEffects of HDL on Endothelial Nitric Oxide BioavailabilityAre There Other Biomarkers than the Total HDL-C?HDL-Induced Cell Signaling: Future Challenges and OpportunitiesTranscriptional Regulation of the ABCG1 GeneNovel LXR AgonistsIV Treatments for Dyslipidemias and Dysfunction of HDLThe Beneficial Effects of HDL in Pancreatic Beta CellsApoA-I MimeticsEstablished Primary Regulators of Plasma HDL CholesterolDetoxification of Plasma and External FluidsSmoking Cessation Intervention to Increase Plasma HDL ConcentrationHDL SubclassesPosttranscriptional Regulation of HDL Genes by Noncoding RNAs and microRNAsBiological MechanismsHDL-VHDL Infusionsn-3 Polyunsaturated Fatty AcidsEffects of Exercise on Prevention and Treatment of Cardiometabolic RiskReconstituted HDLs and HDL MimeticsTranscytosis of apoA-I and HDL by Endothelial CellsGeneralSystemic Lupus Erythematosus (SLE)HDLs and Nitric Oxide (NO)HDL Conversion and RemodelingLipidomeMechanisms of ProtectionAtherothrombosisEffects of HDL in Rat Neonatal CardiomyocytesChronic Kidney Disease: Epidemiology and PathophysiologyTranscriptional Regulation of the CETP GeneHDLs and Acute Stroke: Experimental ModelsEffects of Alcohol on HDL and Cardiovascular RiskATI-5261HDL FunctionPhospholipid Transfer ProteinComplexity of HDLHuman Apo A-I Gene Transfer Reduces Diabetes-Associated Cardiac Apoptosis and Improves the Cardiac Endothelial IntegrityTranscriptional Regulation of the Apolipoprotein E GeneABCG1Mechanisms Under Physiological ConditionsScavenger Receptor BIMechanisms Under Physiological ConditionsEffects of HDL on LDL OxidationNiacinBacterial PathogensSelective DelipidationEstablished Secondary Regulators of Plasma HDL CholesterolLipid-Modulating Therapy in CKD PatientsMetal Oxides, Carbon Nanotubes and PLGA NanoparticlesAntisense OligonucleotidesIRI in In Vivo ModelsAutoimmune Diseases: The Role of AutoantibodiesNiacinDysregulation of Proteins in HDL MetabolismApoA-I Mutations May Induce Hypertriglyceridemia and/or HypercholesterolemiaImpact of Systemic Inflammation and Autoimmune Diseases on apoA-I and HDL Plasma Levels and FunctionsPotential Mechanisms for the Smoking-Related Reduction in HDL-CHDL Confer Protection Against Ischaemia Reperfusion InjuryTranscriptional Regulation of the apoA-I Gene in the LiverRegulation of HDL Genes: Transcriptional, Posttranscriptional, and PosttranslationalCholesterol Ester Transfer Protein Transgenic MiceLoss of Protective Proteins or LipidsStatinsRemodeling and Catabolism of HDLHDL and Atherothrombotic Vascular DiseaseBeneficial Effects of Selective HDL-Raising Gene Transfer on Cardiac Remodelling and Cardiac Function After Myocardial Infarction in MiceMacrophage Cholesterol Efflux and Reverse Cholesterol TransportmiRNAs: Biogenesis and FunctionFunctionality of HDL: Antioxidation and Detoxifying EffectsSR-BIApolipoprotein A-IInsights from Intercrossing of the Different Knockout MiceMissing HeritabilityVasculitisProtective Role of HDL: Evidence from Epidemiological StudiesHigh-Density Lipoproteins and Oxidative StressApo A-I and Sphingosine-1-Phosphate Mediate the Cytoprotective Effects of HDLDevelopment of Topical HDL Therapy for Cutaneous Wound HealingHigh HDL Levels Do Not Add to the ProtectionPossibility of Functional Restoration of HDLNovel Insight into HDL BiologyLipoproteins in the BrainClinical Relevance of the Aberrant HDL PhenotypesCurrent StateEffect on HDL Ability to Preserve Endothelial Cell HomeostasisHDLs and Sphingosine 1-PhosphateApoA-I Mimetic PeptidesATP-Binding Cassette Transporter G1Purified ApoA-I InfusionsDoes HDL Play a Causal Role in the Pathogenesis of Diabetes?Adult Mouse CardiomyocytesTranscriptional Regulation of the ABCA1 GeneHigh-Density Lipoproteins: Antioxidative FunctionHuman Apo A-I Gene Transfer Influences Metabolic Parameters in Streptozotocin-Induced Diabetes MellitusPON1 as an AntioxidantmiRNAsTime Trends in Total HDL-CHDL/apoA-I Structure and FunctionInflammatory DiseasesAntibodiesHuman Apo A-I Gene Transfer Attenuates DiabetesAssociated Oxidative Stress, Cardiac Fibrosis,The Origin and Metabolism of Preb-HDL SubpopulationsAntisense Oligonucleotides, microRNAs, and AntibodiesCarbohydrate and Extrinsic SugarsPosttranscriptional Modulation of HDL Metabolism by miRNAsCSL-111 and CSL-112 InfusionsHDL FractionsStructure of HDL: Particle Subclasses and Molecular ComponentsScavenger Receptor BINovel PPAR AgonistsII Pathology of HDLPleiotropic Effects of HDLsStructural and Functional Modifications of HDL in CKD PatientsIncrease of Molecules within HDL with a Fatal Function in the Vascular WallHDL and Viral InfectionsDe Novo Synthesis of HDL and HDL BindingHDL Cholesterol as a Risk Factor for Atherosclerosis and Its ComplicationsHIV InfectionHepatitis, Dengue and Other VirusesApoE and apoA-IV Participate in the Biogenesis of HDL Particles Containing the Corresponding ProteinsEffects of HDLs on Smooth Muscle CellsAcknowledgementHDL Particle SizeCurrent StatePON1 and OrganophosphatesLDL-Cholesterol Lowering Approaches: Proprotein Convertase Subtilisin/Kexin Type 9 Blocking AntibodiesEffect on HDL Antioxidant PropertiesHDL Quality and Cholesterol EffluxEffects of HDL on Endothelial Cell Apoptotic PathwaysBeyond the Genetics of HDL: Why Is HDL Cholesterol Inversely Related to Cardiovascular Disease?Preservation of Endothelial IntegrityRheumatoid Arthritis (RA)Mechanisms Under Physiological ConditionsEffects of Exercise on HDLATP-Binding Cassette Transporter A1 (ABCA1)Effects of Dietary Fatty Acids and Cholesterol on HDL FunctionTranscriptional Regulation of the HDL Receptor SR-BIApproaches to Antibody Therapy for the Increase of HDLCholesterol LevelsHDLs, Diabetes, and Metabolic SyndromeImpairment of the Anti-Oxidative Effects of HDL in Patients After Surgery and With Cardiovascular DiseasePrefaceHDL LipidsTranscriptional Regulation of the PLTP GeneapoMRCT in Animal ModelsETC-642Relationship Between Lipid Raft Modulation and Lymphocyte FunctionGeneral Innate Host Defense Mechanisms Exerted by HDL After Bacterial InfectionEmerging Small Molecule DrugsDyslipidemia, Lipid-Modulating Therapy, and Cardiovascular Risk in CKD PatientsStatinsFuture PerspectivesApoA-I-Induced Cell Signaling Directly Mediated by ABCA1HDL Biogenesis, Remodeling, and CatabolismEffects of Regular Aerobic ExerciseHepatic Lipase and Endothelial LipaseMouse Models of Disturbed HDL MetabolismImpairment of the Endothelial Anti-Apoptotic Effects of HDL in Patients with Cardiovascular DiseaseEffect of Antibodies Used for the Treatment of Chronic Inflammatory Diseases on HDL Antiatherogenic FunctionsCholesteryl Ester Transfer Protein InhibitorsFrom LDL Retention to Atheroma FormationHDL and DietI Physiology of HDL Biological MechanismsMechanisms Under Physiological ConditionsABCA1-Mediated Lipid Efflux to Lipid-Poor apoA-IHDL SubclassesApoA-Iand HDL-Induced Cell Signaling Indirectly Mediated by ABCA1 and/or ABCG1Interactions of HDLs with the EndotheliumMechanisms Under Physiological ConditionsHuman Apo A-I Gene Transfer Attenuates Diabetic CardiomyopathyType 2 Diabetes Mellitus and the Metabolic SyndromeCholesterol Efflux and Reverse Cholesterol TransportModulation of Spinghosine-1-Phosphate (S1P)/ S1P-Receptor Axis and Lymphocyte FunctionInflammatory Bowel DiseasesInhibition of LDL Modification by HDLsPhospholipid Transfer ProteinInterference with Macrophage Differentiation and ActivationThe Role of Cubilin in apoA-I and HDL Catabolism by the KidneyHDL ApolipoproteinsLecithin/Cholesterol Acyltransferase (LCAT)HDL and Bacterial InfectionsHDL and Reverse Cholesterol TransportSmoking CessationApoA-I-Induced Cell Signaling Indirectly Mediated by b-ATPase and P2Y12/13 ADP ReceptorEndothelial Anti-Inflammatory Effects of HDLDysfunctional HDL: From StructureFunction-Relationships to BiomarkersInsulin Resistance, Hypertriglyceridemia, and Decreased HDL Cholesterol LevelsPsoriasisPreservation of Endothelial FunctionProtective Effects of HDL on the KidneySignal Transduction by HDL: Agonists, Receptors, and Signaling CascadesApoA-I-Based Infusion TherapySuppression of Monocyte ExtravasationHDL Particle NumberParasitesDeterminants of Plasma HDL Cholesterol LevelsPON1 and Bacterial PathogensIn Vitro Effects of HDL on CardiomyocytesInteraction of HDL with LPS and Gram-Negative BacteriaHDL-C in Diseases and ConditionsAlterations of the Cholesterol Efflux Capacity of HDL in Cardiovascular Disease“Real” HDL ParticlesModified ApoA-IHDL-Induced Cell Signaling Mediated by SR-BIProteomeCurrent StateCholesteryl Ester Transfer ProteinMyocardial InjuryLaboratory Tests to Measure HDL FunctionInteraction of HDL with LTA and Gram-Positive BacteriaApo A-I and S1P Confer Cardioprotective Effects on HDLAntioxidative StressEffects of Substituting Dietary Saturated Fatty AcidsFFAs and Decreased HDL LevelsImpaired Endothelial Anti-Inflammatory Effects of HDL in Patients with CAD, Diabetes, or Chronic Kidney DysfunctionEffects on Cholesterol Efflux CapacityEffects of Alcohol on HDL Atheroprotective FunctionsSmoking and HDL-C ConcentrationImpaired HDL Capacity to Stimulate NO Production in Patients with Cardiovascular DiseaseLow HDL Cholesterol Levels in Diabetes and Metabolic SyndromeSources of FundingEndothelial Cell Integrity, EPCs and Antiapoptotic ActionHDL Metabolism, Subclasses, and CatabolismABCA1Regulation of Genes Involved in HDL Metabolism at the Transcriptional LevelATP-Binding Cassette Transporter A1III Possible Indications and Target Mechanisms of HDL TherapyPlasma HDLs in the BrainEffect of Weight-Loss Therapies on HDL Concentration and FunctionAnti-inflammatory and Antiprotease PropertiesHuman Apo A-I Gene Transfer Reduces Diabetes-Induced Cardiac InflammationNiacinMolecular Components of HDLHDL and Parasitic InfectionsHeterogeneity of Antioxidant Activity of HDL ParticlesHDL-Induced Cell Signaling Mediated by S1PAntithrombotic ActionsRVX-208Dietary MUFATherapeutic Potential of HDL in Cardioprotection and Tissue RepairFibratesHDL in the Test TubeTotal HDL-C Modulated by Environmental FactorsFibrates: Pleiotropic Effects of HDLs—In Vitro and In Vivo DataEffects of HDL on Insulin Sensitivity and Glucose Utilization by Skeletal MuscleTranscriptional Regulation of the Bile Acid Transporters ABCG5/ABCG8PhysiologyHDLs in the Cerebral CompartmentChanges of HDL Apolipoproteins (Modifications and Levels)Effects on HDL Subclass DistributionImpact of Adiposity on HDL Concentration and FunctionHCV InfectionCholesterol Efflux to Lipidated HDLHigh-Density Lipoprotein: Structural and Functional Changes Under Uremic Conditions and the Therapeutic ConsequencesCER-001 InfusionsSerum Cholesterol Efflux Capacity (CEC)Therapeutic Antisense Oligonucleotides to Treat DyslipidemiaEffects of Established Hypolipidemic Drugs on HDL Concentration, Subclass Distribution, and FunctionBiogenesis of HDLCurrent StateTranscriptional Regulation of the Human apoM Gene in the LiverFHDL in Infectious Diseases and SepsisStatinsThe Structure of HDLFuture Approaches of Epidemiological StudiesFibratesHDL Cholesterol as a Risk Factor for Other DiseasesFibratesEffects of HDLs on Vascular Lipid and Lipoprotein HomeostasismiRNA-Based TherapyFuture PerspectivesMicromanaging Cholesterol Efflux, RCT, HDL Levels, and HDL FunctionATP-Binding Cassette Transporter G1Dyslipidemia in CKD PatientsHDL and Lifestyle InterventionsAnti-inflammatory EffectsHigh-Density Lipoproteins, Paraoxonase-1StatinsFibratesHDL and Tissue Repair: Modulation of EPC Biology via SR-BIEffect of HDL on StrokeAntithrombotic Effects of HDLsBiological MechanismsStatinsTotal HDL-C in Various PopulationsCholesterol Efflux as the First Step of Reverse Cholesterol Transport (RCT)Effects on Plasma HDL-C ConcentrationWeight LossRole of Ecto-F1-ATPase/P2Y13 Pathway in Hepatic HDL ClearancePosttranslational Mechanisms of HDL RegulationPharmacologyBiological MechanismsPleiotropyFIRI in the Isolated Heart ModelHDL Protein Cargo and Prognostic BiomarkersSuppression of MyelopoiesisVaccines Against Atherosclerosis: HDLs and Acute Stroke (In Vivo Data)Alcohol Intake and HDL-CHDL and MycobacteriaHigh-Density Lipoproteins in StrokeFuture PerspectivesHDL and apoA-I as Members of the Innate Immune SystemLecithin-Cholesterol AcyltransferaseFX-5AImpact of Anti-inflammatory Treatments
Found a mistake? Please highlight the word and press Shift + Enter  
Business & Finance
Computer Science
Language & Literature
Political science